Skip to main content

Role of PSIP1 in prostate cancer development and drug resistance

Objective

Understanding the cancer-specific genetic alterations is fundamental to devising novel treatment modalities. This project aims at understanding the role of PSIP1, posterior homeotic domain-containing transcription factors (HOX TFs) and androgen receptor (AR) in transcriptional regulation of prostate cancer cells. These transcriptional regulators are integral to the normal cell homeostasis and are dysregulated in various cancers. Through the preliminary data and analysis, this proposal recognises an interlink between these three factors and the ability of this trio in mediating a cancer-specific transcriptional alteration through activation of cancer-promoting transcriptional enhancers. Using a powerful combination of genome editing, functional genomics and bioinformatics, this proposal aims to discover altered transcriptional programme and its impact on cancer progression and treatment resistance. This project combines the expertise of the researcher in cancer biology with the competences of the host in epigenetics and functional genomics. This project will impart the talented researcher with comprehensive research training in chromatin biology and functional cancer genomics at an elite research Institute, in order to increase his prospects to become an independent research leader. The researcher will also profit from postdoctoral training opportunities in transferable skills available at the host's institution. Completion of the research and training objectives will significantly shape the development of the researcher into an independent leader, assign him a firm place in the European research network

Field of science

  • /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance
  • /medical and health sciences/clinical medicine/oncology/cancer/prostate cancer

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

QUEEN MARY UNIVERSITY OF LONDON
Address
327 Mile End Road
E1 4NS London
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 224 933,76